Clinical Tumor Immunology

Content: 
Front Matter, Page iii
Copyright, Page iv
THE IMMUNOLOGICAL DREAM OF AN ONCOLOGIST, Pages xi-xii, JOSEPH WYBRAN, MAURICE J. STAQUET
EORTC, AIM, STRUCTURE AND ACTIVITY, Pages xiii-xv, M.J. STAQUET, J. WYBRAN
BIOLOGICAL ACTIVITIES OF THE CIRCULATING THYMIC HORMONE, Pages 3-7, JEAN-FRANÇOIS BACH
MACROPHAGE SECRETIONS AFFECTING THE GROWTH OF OTHER CELLS, Pages 9-18, FERDY J. LEJEUNE
IMMUNE CELLULAR MECHANISMS AT THE SITE OF THE TUMOR, Pages 19-28, E.H. BETZ, L.J. SIMAR
T-CELL ROSETTES IN HUMAN CANCER, Pages 31-40, JOSEPH WYBRAN, H. HUGH FUDENBERG
CELL-MEDIATED CYTOTOXICITY IN VITRO. MECHANISMS AND RELEVANCE TO TUMOR IMMUNITY, Pages 41-46, J.-C. CEROTTINI, K.T. BRUNNER
FUNCTION AND EVALUATION OF HUMAN K-CELLS, Pages 47-53, I.C.M. MacLENNAN
LYMPHOCYTE STIMULATION TEST FOR DETECTION OF TUMOR SPECIFIC REACTIVITY IN HUMANS, Pages 55-68, F. VÁNKY, E. KLEIN, J. STJERNSWÄRD
THE LEUCOCYTE MIGRATION TECHNIQUE IN STUDIES OF TUMOR-DIRECTED CELLULAR IMMUNITY IN MALIGNANT MELANOMA, Pages 69-76, ALISTAIR J. COCHRAN, RONA M. MACKIE, CATHERINE E. ROSS, LINDSAY J. OGG, ALAN M. JACKSON
DETECTION OF CELL-MEDIATED IMMUNITY AGAINST TUMOR-ASSOCIATED ANTIGENS OF HUMAN BREAST CARCINOMA BY MIGRATION INHIBITION AND LYMPHOCYTE-STIMULATION ASSAYS, Pages 77-86, J.L. McCOY, J.H. DEAN, G.B. CANNON, B.A. MAURER, R.K. OLDHAM, R.B. HERBERMAN
THE USE OF CEA (CARCINOEMBRYONIC ANTIGEN) AND OTHER CARCINOFOETAL ANTIGENS IN HUMAN CANCER, Pages 89-103, S. VON KLEIST
HL-A AND CANCER, Pages 107-111, A. GOVAERTS
IMMUNOLOGICAL APPROACHES TO THE IDENTIFICATION OF LEUKAEMIC CELLS, Pages 115-121, M.F. GREAVES, G. BROWN, D. CAPELLARO, G. JANOSSY, T. REVESZ
LYMPHOCYTE MEMBRANE MARKERS IN B-CELL PROLIFERATIONS AND HUMAN NON-HODGKIN'S LYMPHOMAS, Pages 123-130, J.C. BROUET, J.L. PREUD'HOMME, M. SELIGMANN
CLASSIFICATION OF LEUKEMIAS AND HEMATOSARCOMAS BASED ON CELL MEMBRANE MARKERS AND SCANNING ELECTRON MICROSCOPY, Pages 131-144, D. BELPOMME, D. DANTCHEV, R. JOSEPH, A. SANTORO, F. FEUILHADE DE CHAUVIN, N. LELARGE, D. GRANDJON, D. PONTVERT, G. MATHE
PRECLINICAL APPROACHES IN TUMOR IMMUNOCHEMOTHERAPY, Pages 147-157, ABRAHAM GOLDIN, DAVID P. HOUCHENS
LEVAMISOLE IN RESECTABLE HUMAN BRONCHOGENIC CARCINOMA, Pages 159-168, W. AMERY
MEDIATION OF IMMUNE RESPONSES TO HUMAN TUMOR ANTIGENS WITH “IMMUNE” RNA, Pages 169-190, YOSEF H. PILCH, DIETER FRITZE, DAVID H. KERN
TRANSFER FACTOR: THE CURRENT PICTURE, WITH SPECIAL REFERENCE TO HUMAN CANCER, Pages 191-205, H. HUGH FUDENBERG
NEW FRONTIERS OF CANCER ACTIVE IMMUNOTHERAPY, Pages 207-222, G. MATHE
THE IMMUNOTHERAPY OF ACUTE MYELOBLASTIC LEUKAEMIA, Pages 223-232, J.M.A. WHITEHOUSE
IMMUNOTHERAPY OF HUMAN SOLID TUMORS: PROLONGATION OF DISEASE-FREE INTERVAL AND SURVIVAL IN MALIGNANT MELANOMA, BREAST AND COLORECTAL CANCER, Pages 233-250, JORDAN U. GUTTERMAN, GIORA M. MAVLIGIT, MICHAEL A. BURGESS, JUAN O. CARDENAS, RICHARD C. REED, GEORGE R. BLUMENSCHEIN, JEFFREY A. GOTTLIEB, CHARLES M. McBRIDE, EVAN M. HERSH
ABSTRACTS, Pages 251-265
AUTHOR INDEX, Pages 267-277
SUBJECT INDEX, Pages 279-282